Serum ferritin levels in long COVID patients in the ME/CFS group and non-ME/CFS group. by Satoru Morita (353644)

Top 10 significant functional annotations of down-regulated DEGs. by Meitner Cadena (22216261)

“…Functional annotations are ordered by decreasing significance, with color indicating significance level based on the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”

Variations in the prevalence of OASI in France between 2010 and 2021 according to the classification for episiotomy practices. by Raphaele Houlbracq (20558509)

Subjects:

Trends in the characteristics of women giving birth vaginally in France between 2010 and 2021. by Raphaele Houlbracq (20558509)

Subjects:

Variations in the prevalence of episiotomy in France between 2010 and 2021 according to the classification for episiotomy practices. by Raphaele Houlbracq (20558509)

Subjects:

Flow chart. by Raphaele Houlbracq (20558509)

Subjects:

pmed.1004501.t001 - Episiotomies and obstetric anal sphincter injuries following a restrictive episiotomy policy in France: An analysis of the 2010, 2016, and 2021 National Perinat... by Raphaele Houlbracq (20558509)

Subjects:

<i>Porphyromonas gingivalis</i> LPS pretreated by ozone ultrafine bubble water induces decreased TLR2 activation. by Mana Endo (22430706)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. by Zahra Motahari (6814013)

Subjects:

The effect of MAGMAS inhibition on mitochondrial respiration and acidification rate in D425 cells. by Zahra Motahari (6814013)

Subjects:

PAM16 correlation with N-MYC. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition on mitochondrial activity in medulloblastoma cells. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition reduces DAOY cells migration. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition induces medulloblastoma cell death. by Zahra Motahari (6814013)

Subjects:

BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

Subjects:

Expression of MAGMAS in medulloblastoma. by Zahra Motahari (6814013)

Subjects:

BT9 exhibits a dose- and time-dependent cytotoxic effect on medulloblastoma. by Zahra Motahari (6814013)

Subjects:

Schematic of the sound velocity profile in the experimental sea area. by Du Siqi (20721422)

Subjects: